General Information
Version
03
Revision date
2023-09-15
Product name
THROMBOPLASTIN
1.2.1 Relevant identified uses
For in vitro diagnostic use
1.2.2. Uses advised against
Other uses are not expected
Manufacturer Name
Instrumentation Laboratory Co
Emergency telephone
+44 (0) 3700 492 795, +1 215 207 0061
Icons in SDS
Company Information
company name
Instrumentation Laboratory Co
e-mail address of the competent person responsible for the Safety Data Sheet
infosds@werfen.com
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
Under normal conditions of use, the mixture does not cause adverse effects to humans and to the environment. Any additional information concerning the risks for health and/or the environment are given in sections 11 and 12 of this sheet
Other hazards which do not result in classification
Warning: The mixture contains acetone rabbit brain powder. This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
2.1 Classification of the substance or mixture
Not classified Adverse physicochemical, human health and environmental effects Under normal conditions of use, the mixture does not cause adverse effects to humans and to the environment. Any additional information concerning the risks for health and/or the environment are given in sections 11 and 12 of this sheet. 2.2. Label elements Labelling according to Regulation (EC) No. 1272/2008 [CLP] No labelling applicable 2.3. Other hazards Other hazards which do not result in classification : Warning: The mixture contains acetone rabbit brain powder. This substance/mixture does not meet the PBT criteria of REACH regulation, annex XIII This substance/mixture does not meet the vPvB criteria of REACH regulation, annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % SECTION 3: Composition/information on ingredients 3.1. Substances Not applicable 3.2. Mixtures Comments : Composition: powder containing organic components and acetone rabbit brain powder. This mixture does not contain any substances to be mentioned according to the criteria of section 3.2 of REACH Annex II SECTION 4: First aid measures 4.1. Description of first aid measures First-aid measures after inhalation : If inhaled, move person to fresh air. If breathing is difficult, oxygen should be administered. Get medical advice if adverse symptoms appear. First-aid measures after skin contact : Remove contaminated clothes and shoes. Wash immediately affected area with soap or mild detergent and plenty of water until the removal of the mixture (15-20 minutes). Get medical advice if adverse symptoms appear. First-aid measures after eye contact : Wash immediately with plenty of water or normal saline for at least 15 minutes. Keep eyelid open with the finger. Get medical advice if adverse symptoms appear. First-aid measures after ingestion : If swallowed rinse mouth with plenty of water provided person is conscious. Do not induce vomiting. Get medical advice if adverse symptoms appear. 4.2. Most important symptoms and effects, both acute and delayed Symptoms/effects : Acute symptoms and effects are not known. Chronic symptoms : Delayed symptoms and effects are not known. 4.3. Indication of any immediate medical attention and special treatment needed Treat symptomatically. SECTION 5: Firefighting measures 5.1. Extinguishing media Suitable extinguishing media : CO2. Dry powder. Foam. Water spray. Unsuitable extinguishing media : Not known. 5.2. Special hazards arising from the substance or mixture Hazardous decomposition products in case of fire : Thermal decomposition or combustion may generate toxic and hazardous fumes of COx, NOx, SOx, HBr. 5.3. Advice for firefighters Protection during firefighting